Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Dr. Jingwu Zang
|
| gptkbp:country |
gptkb:China
|
| gptkbp:focus |
immuno-oncology
autoimmune diseases |
| gptkbp:foundedYear |
2014
|
| gptkbp:headquartersLocation |
gptkb:Shanghai
|
| https://www.w3.org/2000/01/rdf-schema#label |
IMAB
|
| gptkbp:industry |
biopharmaceuticals
|
| gptkbp:product |
gptkb:felzartamab
uliledlimab |
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:IMAB
|
| gptkbp:website |
https://www.imabio.com/
|
| gptkbp:bfsParent |
gptkb:I-Mab_Biopharma
|
| gptkbp:bfsLayer |
7
|